- Home
- BCPC vs CZR Comparison
BCPC vs CZR Comparison
Compare BCPC & CZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCPC | CZR |
|---|---|---|
| Founded | 1967 | 1937 |
| Country | United States | United States |
| Employees | N/A | 50000 |
| Industry | Major Chemicals | Hotels/Resorts |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.7B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BCPC | CZR |
|---|---|---|
| Price | $160.13 | $27.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $176.00 | $31.92 |
| AVG Volume (30 Days) | 163.3K | ★ 3.4M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 20.87 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | $799,023,000.00 | ★ $1,473,504,000.00 |
| Revenue This Year | $8.47 | $3.56 |
| Revenue Next Year | $4.89 | $2.48 |
| P/E Ratio | $128.96 | ★ N/A |
| Revenue Growth | 13.56 | ★ 65.03 |
| 52 Week Low | $139.17 | $17.86 |
| 52 Week High | $183.90 | $31.58 |
Technical Indicators
Market Signals| Indicator | BCPC | CZR |
|---|---|---|
| Relative Strength Index (RSI) | 40.23 | 53.31 |
| Support Level | $159.00 | $27.22 |
| Resistance Level | $165.24 | $28.28 |
| Average True Range (ATR) | 3.58 | 0.97 |
| MACD | -0.10 | -0.05 |
| Stochastic Oscillator | 47.00 | 73.24 |
Price Performance
Historical ComparisonAbout BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (48% of 2025 EBITDAR) and regional (49%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2025. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.